Pfizer Ltd.
NSE: PFIZER | BSE: 500680
₹4,859.30
₹-95.40
(-1.93%)
As on 18-May-2026IST
Market cap
₹22,234 Cr
Revenue (TTM)
₹2,520 Cr
P/E Ratio
30.8
P/B Ratio
5.3
Div. Yield
1.5 %
Quality Score
9/10
Growth Score
7/10
Valuation Score
5/10
Momentum Score
5/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹722 Cr
-
ROE
19.6 %
-
ROCE
26.2 %
-
Industry P/E
33.65
-
EV/EBITDA
17.5
-
Debt to Equity
0
-
Book Value
₹918.7
-
EPS
₹165.8
-
Face value
10
-
Shares outstanding
45,747,732
10 Years Aggregate
CFO
₹3,793.77 Cr
EBITDA
₹6,154.93 Cr
Net Profit
₹4,993.04 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pfizer
| -2.6 | -2.0 | -3.8 | 10.1 | 8.4 | -1.4 | 10.5 |
|
BSE Healthcare
| 8.9 | 8.8 | 9.5 | 11.4 | 27.0 | 14.4 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Pfizer
| -6.0 | 23.8 | -3.7 | -12.3 | -4.2 | 20.7 | 47.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Pfizer
|
4,859.3 | 22,234.1 | 2,519.7 | 722.4 | 33.6 | 18.8 | 30.8 | 5.3 |
| 3,214.1 | 40,117.5 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 38 | 8.9 | |
| 8,513.5 | 21,254.5 | 2,177.5 | 200.9 | 11.3 | 26.5 | 105.8 | 25.6 | |
| 1,986.1 | 15,107.7 | 2,187.2 | 649.7 | 31.5 | 19 | 23.6 | 4.2 | |
| 1,820.2 | 11,137.9 | 1,196.4 | 149.4 | -- | 27.5 | 60.2 | 14.9 | |
| 1,340.8 | 18,572.2 | 3,078.2 | 469.4 | 26.4 | 14.9 | 43 | 5.1 | |
| 2,125.3 | 34,116.3 | 4,147.8 | 709.5 | 22.3 | 18.3 | 48.1 | 8.2 | |
| 5,255.0 | 8,734.4 | 1,348.5 | 293.5 | 28.1 | 50.7 | 29.8 | 12.5 | |
| 476.2 | 9,329.3 | 1,432.0 | 149.0 | 19.1 | 7.9 | 62.2 | 3.7 | |
| 1,151.4 | 10,603.1 | 4,858.7 | 574.1 | 14.9 | 19.7 | 19.1 | 3.6 |
Shareholding Pattern
View DetailsNews & Analysis
All News
3 min read•By Markets Desk
3 min read•By Research Desk
2 min read•By Research Desk
Diversified Equity Funds: Not Dead Yet
4 min read•By Research Desk
About Pfizer
Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones,... cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients. It sells its products through a network of independent distributors primarily under various brand names. The company was incorporated in 1950 and is headquartered in Mumbai, India. Read more
-
Incorporated
1950
-
Chairman
Pradip Shah
-
Managing Director
Meenakshi Nevatia
-
Group
Pfizer - MNC
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsIntimation Of Date Of Annual General Meeting
12-May-2026Corporate Action-Board approves Dividend
12-May-2026No News & Announcements are available.
FAQs for Pfizer
What is the current share price of Pfizer Ltd Today?
The share price of Pfizer Ltd is ₹4,859.30 (NSE) and ₹4,860.15 (BSE) as of 18-May-2026 IST. Pfizer Ltd has given a return of 8.37% in the last 3 years.
What is the current PB & PE ratio of Pfizer Ltd?
The P/E ratio of Pfizer Ltd is 30.78 times as on 18-May-2026, a 9 discount to its peers’ median range of 33.65 times.
The P/B ratio of Pfizer Ltd is 5.29 times as on 18-May-2026, a 15 premium to its peers’ median range of 4.59 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
23.86
|
4.34
|
|
2024
|
34.80
|
5.34
|
|
2023
|
25.40
|
4.94
|
|
2022
|
32.50
|
6.95
|
|
2021
|
41.57
|
8.64
|
What is the 52 Week High and Low of Pfizer Ltd?
The 52-week high and low of Pfizer Ltd are Rs 5,993.00 and Rs 4,405.00 as of 19-May-2026.
What is the market cap of Pfizer Ltd?
Pfizer Ltd has a market capitalisation of ₹ 22,234 Cr as on 18-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Pfizer Ltd?
Before investing in Pfizer Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.